HALO logo
halo search icon
Hikma Pharmaceuticals Plc

GBP14.78

Price Change Indicator
0.23 (1.58%)
Hikma Pharmaceuticals Plc
HIK · LON

Hikma Pharmaceuticals Plc

Start Trading HIK for Free

GBP14.78

Price Arrow0.23 (1.58%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusEngulfing BullishFakey Shakey - ShortHALO 100HALO 200HALO AllHALO Price Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Hikma Pharmaceuticals Plc Overview

HIK Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Very Weak

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

About HIK

icon
icon

Telephone

44.20.7399.2760

icon

Address

10 Portman Square, London, Greater London W1H 6AZ

Description

Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, and Rx. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Rx segment includes oral, respiratory and other generic and specialty products supplied to the North American retail market, leveraging state-of-the-art manufacturing facility in Columbus, Ohio. The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.

HIK Price Chart

Key Stats

Market Cap

GBP3.19B

PE

11.20

EV/EBITDA

7.4

Dividends Overview

DIV Yield

4%

Franking

0%

Ex Dividend Date (est.)

19-Mar-26

Market Data

52 weeks range

Low 11.87 - 21.64

Trade Value (12mth)

US$4,431,068.00

1 week

2.64%

1 month

9.64%

YTD

-2.95%

1 year

-28.87%

All time high

27.68

Key Fundamentals

EPS 3 yr Growth

117.10%

EBITDA Margin

23.30%

Operating Cashflow

$359m

Free Cash Flow Return

10.10%

ROIC

11.30%

Interest Coverage

7.60

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

220m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

19-Mar-26

Next Dividend Pay Date

30-Apr-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

HIK Announcements

Latest Announcements

DateAnnouncements
18 May 26
15 May 26
11 May 26
07 May 26
05 May 26

HIK Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.861.621.82locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.851.611.81locklocklock
Growth
 %locklocklocklock2.588.512.4locklocklock
PE
 Xlocklocklocklock25.815.711.2locklocklock
EV/EBITDA
 Xlocklocklocklock8.68.57.4locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

19-Mar-26

DIV Yield

4%

Franking Level

0%

DPSg

4.1%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Hikma Pharmaceuticals Plc (HIK:LON)?
Halo FAQ
The current share price of Hikma Pharmaceuticals Plc (HIK:LON) is GBP£14.78.
What is the 52-week high share price for Hikma Pharmaceuticals Plc (HIK:LON)?
Halo FAQ
The 52-week high share price for Hikma Pharmaceuticals Plc (HIK:LON) is GBP£21.64.
What is the 52-week low share price for Hikma Pharmaceuticals Plc (HIK:LON)?
Halo FAQ
The 52-week low share price for Hikma Pharmaceuticals Plc (HIK:LON) is GBP£11.87.
What is the dividend yield for Hikma Pharmaceuticals Plc (HIK:LON)?
Halo FAQ
The current TTM dividend payout for Hikma Pharmaceuticals Plc (HIK:LON) is 4.00.
What was Hikma Pharmaceuticals Plc (HIK:LON) last dividend payment?
Halo FAQ
The last dividend payment of Hikma Pharmaceuticals Plc (HIK:LON) is GBP£0.36.
What is the franking level for Hikma Pharmaceuticals Plc (HIK:LON)?
Halo FAQ
Hikma Pharmaceuticals Plc (HIK:LON) has a franking level of 0.00%.
In which sector is Hikma Pharmaceuticals Plc (HIK:LON) classified?
Halo FAQ
Hikma Pharmaceuticals Plc (HIK:LON) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Hikma Pharmaceuticals Plc (HIK:LON)?
Halo FAQ
The current P/E ratio for Hikma Pharmaceuticals Plc (HIK:LON) is 11.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial